Stay updated on BMS-936558 vs Standard Chemo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the BMS-936558 vs Standard Chemo in Advanced Melanoma Clinical Trial page.

Latest updates to the BMS-936558 vs Standard Chemo in Advanced Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe completed CheckMate 037 study record is available, with details on nivolumab versus chemotherapy for advanced melanoma, including outcomes, eligibility criteria, and study locations.SummaryDifference91%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide notice about the terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check46 days agoChange DetectedThe 403 Forbidden error page content was removed. The page now displays the standard ClinicalTrials.gov study record content instead of the error message.SummaryDifference0.5%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating that access to the study record is blocked.SummaryDifference18%

Stay in the know with updates to BMS-936558 vs Standard Chemo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-936558 vs Standard Chemo in Advanced Melanoma Clinical Trial page.